AAL vs EBON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

AAL

38.8
AI Score
VS
EBON Wins

EBON

52.1
AI Score

Investment Advisor Scores

AAL

39score
Recommendation
AVOID NEW MONEY

EBON

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AAL EBON Winner
Forward P/E 12.1065 0 Tie
PEG Ratio 0.2247 0 Tie
Revenue Growth 19.3% 9.5% AAL
Earnings Growth -88.2% 0.0% EBON
Tradestie Score 38.8/100 52.1/100 EBON
Profit Margin -0.8% -181.5% AAL
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY STRONG BUY EBON

Relative Price Performance (Last 90 Days)

AAL 1M: +12.9% · 3M: -10.2% EBON 1M: -15.4% · 3M: -14.9%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.2 · Price: $13.31

EBON

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 43

RSI (14): 42.8 · Price: $1.65

Fundamentals Snapshot

Metric AAL EBON
Market Cap — —
Forward P/E 14.1 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.0% -3.2%
EPS -0.73 -1.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EBON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.